SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-092990
Filing Date
2022-08-19
Accepted
2022-08-19 16:30:40
Documents
12
Period of Report
2022-08-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2224097d2_8k.htm   iXBRL 8-K 26589
  Complete submission text file 0001104659-22-092990.txt   199592

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA agrx-20220815.xsd EX-101.SCH 3060
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE agrx-20220815_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agrx-20220815_pre.xml EX-101.PRE 22613
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2224097d2_8k_htm.xml XML 3611
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 221181238
SIC: 2834 Pharmaceutical Preparations